Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
None | ||||||
Postponed | ||||||
None | ||||||
Withdrawn | ||||||
None | ||||||
New Terms | ||||||
Anchiano Therapeutics (ANCN) | Oppenheimer | 2.40 | $14.55 | $14.55 | $34.92 | S/O |
TCR2 Therapeutic (TCRR) | Jefferies/ Leerink Partners/ BMO Capital Markets | 5.00 | $14.00 | $16.00 | $75.00 | S/O |
Harpoon Therapeutics (HARP) | Citigroup/ Leerink Partners | 5.40 | $13.00 | $15.00 | $75.60 | S/O |
Alector (ALEC) | Morgan Stanley/ BofA Merrill Lynch/ Cowen/ Barclays | 9.25 | $18.00 | $20.00 | $175.75 | S/O |
Virgin Trains USA (VTUS) | Barclays/ J.P. Morgan/ Morgan Stanley | 28.33 | $17.00 | $19.00 | $510.01 | S/O |
S/O (Subscribers Only) | ||||||
IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
Week of Jan. 28, 2019 | Manager(s) | Offered | Raised | Price | 2/1/19 | Change |
Gores Metropoulos (GMHIU) (u) | Deutsche Bank Securities/ Credit Suisse/ Goldman Sachs | 37.50 | $375.00 | $10.00 | $10.12 | 1.20% |
Pivotal Acquisition (PVT.U) (u) | Cantor | 20.00 | $200.00 | $10.00 | $10.10 | 1.00% |
Andina Acquisition Corp. III (ANDAU) (u) | Cowen/ Craig-Hallum Capital Group | 10.00 | $100.00 | $10.00 | $10.07 | 0.70% |
PIMCO Energy & Tactical Credit Opportunities Fund (NRGX) | UBS Investment Bank/ BofA Merrill Lynch/ Morgan Stanley/ Wells Fargo Securities/ RBC Capital Markets/ Stifel | 40.00 | $800.00 | $20.00 | $20.10 | 0.50% |
New Fortress Energy (NFE) | Morgan Stanley/ Barclays | 20.00 | $280.00 | $14.00 | $13.95 | -0.36% |
u – unit offering |